Starling Oncology, Inc. Restricted Cash
Starling Oncology, Inc. (DFPH) had Restricted Cash of $0 as of 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-03-16
- 2022-12-31: Restricted Cash $0.00.
- 2022-09-30: Restricted Cash $0.00.
- 2022-06-30: Restricted Cash $0.00.
- 2022-03-31: Restricted Cash $875.00K.
| Period end | Restricted Cash |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-16 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 |
| 2022-03-31 | $875.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $875.00K 10-K · filed 2023-03-16 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |